896114-79-7

Upstream product

• 68-12-2 N,N-dimethyl-formamide 
• 396091-34-2 2-(3-bromophenylethoxy)tetrahydro-2H-pyran 

Downstream Products

• 950503-55-6 (2-methoxy-benzyl)-{3-[2-(tetrahydro-pyran-2-yloxy)-ethyl]-benzyl}-amine 
• 950503-72-7 [3-(2-hydroxy-ethyl)-benzyl]-(3-pyridin-2-yl-propyl)-carbamic acid tert-butyl ester 
• 950504-26-4 (2-pyridin-2-yl-ethyl)-{3-[2-(tetrahydro-pyran-2-yloxy)-ethyl]-benzyl}-carbamic acid tert-butyl ester 
• 950503-56-7 (2-methoxy-benzyl)-{3-[2-(tetrahydro-pyran-2-yloxy)-ethyl]-benzyl}-carbamic acid tert-butyl ester 
• 950504-37-7 (3-{2R-[2-hydroxy-2-(4-hydroxy-2-oxo-2,3-dihydro-benzothiazol-7-yl)-ethylamino]-ethyl}-benzyl)-(1R-methoxymethyl-2-methyl-propyl)-carbamic acid tert-butyl ester 
• 950504-04-8 [3-(2-hydroxy-ethyl)-benzyl]-(4-methoxy-benzyl)-carbamic acid tert-butyl ester 
• 950504-31-1 (1R-methoxymethyl-2-methyl-propyl)-{3-[2-(tetrahydro-pyran-2-yloxy)-ethyl]-benzyl}-amine 
• 950503-52-3 2-{3-[(1S-methoxymethyl-3-methyl-butylamino)-methyl]-phenyl}-ethanol 

Relevant academic research and scientific papers

Benzamide Derivatives, Their Manufacture and Use as Pharmaceutical Agents

Objects of the present invention are the compounds of formula I their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, medicaments containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.

Heterocyclic Carbamate Derivatives, Their Manufacture And Use As Pharmaceutical Agents

Objects of the present invention are the compounds of formula I their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, medicaments containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.

BEZOTHIAZOL DERIVATIVES AS BETA2 ADRENORECEPTOR AGONISTS

The present invention relates to compounds according to formula (I) , a process for preparing them, the intermediate compounds of the process and the use of the compounds in the manufacture of a medicament for use in treating diseases such as ARDS, pulmonary emphysema, bronchitis, bronchiectasis, COPD, asthma and rhinitis. The compounds are beta2 adrenoreceptor agonists.